MXPA04009760A - Nueva asociacion de un agente antitrombotico con aspirina y su uso para tratamiento de enfermedades aterotromboticas. - Google Patents

Nueva asociacion de un agente antitrombotico con aspirina y su uso para tratamiento de enfermedades aterotromboticas.

Info

Publication number
MXPA04009760A
MXPA04009760A MXPA04009760A MXPA04009760A MXPA04009760A MX PA04009760 A MXPA04009760 A MX PA04009760A MX PA04009760 A MXPA04009760 A MX PA04009760A MX PA04009760 A MXPA04009760 A MX PA04009760A MX PA04009760 A MXPA04009760 A MX PA04009760A
Authority
MX
Mexico
Prior art keywords
aspirin
compound
association
pharmaceutically acceptable
pharmaceutical composition
Prior art date
Application number
MXPA04009760A
Other languages
English (en)
Spanish (es)
Inventor
Verbeuren Tony
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MXPA04009760A publication Critical patent/MXPA04009760A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MXPA04009760A 2002-04-05 2003-04-04 Nueva asociacion de un agente antitrombotico con aspirina y su uso para tratamiento de enfermedades aterotromboticas. MXPA04009760A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine
PCT/FR2003/001054 WO2003084525A1 (fr) 2002-04-05 2003-04-04 Nouvelle association d'un antithrombotique et d'aspirine

Publications (1)

Publication Number Publication Date
MXPA04009760A true MXPA04009760A (es) 2004-12-13

Family

ID=28052120

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04009760A MXPA04009760A (es) 2002-04-05 2003-04-04 Nueva asociacion de un agente antitrombotico con aspirina y su uso para tratamiento de enfermedades aterotromboticas.

Country Status (26)

Country Link
US (1) US7618955B2 (cg-RX-API-DMAC7.html)
EP (1) EP1496884B1 (cg-RX-API-DMAC7.html)
JP (1) JP4065853B2 (cg-RX-API-DMAC7.html)
KR (1) KR100645143B1 (cg-RX-API-DMAC7.html)
CN (1) CN1297265C (cg-RX-API-DMAC7.html)
AR (1) AR039253A1 (cg-RX-API-DMAC7.html)
AT (1) ATE329591T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003246774B2 (cg-RX-API-DMAC7.html)
BR (1) BR0309019A (cg-RX-API-DMAC7.html)
CA (1) CA2480697A1 (cg-RX-API-DMAC7.html)
CY (1) CY1105106T1 (cg-RX-API-DMAC7.html)
DE (1) DE60306133T2 (cg-RX-API-DMAC7.html)
DK (1) DK1496884T3 (cg-RX-API-DMAC7.html)
EA (1) EA006978B1 (cg-RX-API-DMAC7.html)
ES (1) ES2264533T3 (cg-RX-API-DMAC7.html)
FR (1) FR2838057B1 (cg-RX-API-DMAC7.html)
GE (1) GEP20074101B (cg-RX-API-DMAC7.html)
MA (1) MA27114A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04009760A (cg-RX-API-DMAC7.html)
NO (1) NO20044700L (cg-RX-API-DMAC7.html)
NZ (1) NZ535430A (cg-RX-API-DMAC7.html)
PL (1) PL371620A1 (cg-RX-API-DMAC7.html)
PT (1) PT1496884E (cg-RX-API-DMAC7.html)
UA (1) UA79457C2 (cg-RX-API-DMAC7.html)
WO (1) WO2003084525A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200407593B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2376994C2 (ru) * 2005-07-22 2009-12-27 Дзе Проктер Энд Гэмбл Компани Составы для снижения риска возникновения вызванной лекарственными средствами аритмии
EP2155195B1 (en) 2007-04-13 2014-07-16 Millennium Pharmaceuticals, Inc. Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor
JP2009001537A (ja) * 2007-06-25 2009-01-08 Lab Servier 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
NO20044700L (no) 2004-10-29
MA27114A1 (fr) 2004-12-20
NZ535430A (en) 2006-09-29
CN1297265C (zh) 2007-01-31
AU2003246774B2 (en) 2007-02-15
US7618955B2 (en) 2009-11-17
GEP20074101B (en) 2007-05-10
DE60306133D1 (de) 2006-07-27
KR100645143B1 (ko) 2006-11-10
AR039253A1 (es) 2005-02-16
WO2003084525A1 (fr) 2003-10-16
FR2838057A1 (fr) 2003-10-10
CN1646111A (zh) 2005-07-27
HK1076034A1 (en) 2006-01-06
AU2003246774A1 (en) 2003-10-20
EP1496884A1 (fr) 2005-01-19
ES2264533T3 (es) 2007-01-01
KR20040098053A (ko) 2004-11-18
CY1105106T1 (el) 2009-11-04
EA200401293A1 (ru) 2005-02-24
EA006978B1 (ru) 2006-06-30
JP2005528376A (ja) 2005-09-22
CA2480697A1 (fr) 2003-10-16
US20050143354A1 (en) 2005-06-30
ZA200407593B (en) 2006-07-26
UA79457C2 (en) 2007-06-25
EP1496884B1 (fr) 2006-06-14
DE60306133T2 (de) 2007-01-04
FR2838057B1 (fr) 2005-07-08
ATE329591T1 (de) 2006-07-15
PL371620A1 (en) 2005-06-27
DK1496884T3 (da) 2006-10-02
JP4065853B2 (ja) 2008-03-26
BR0309019A (pt) 2005-02-01
PT1496884E (pt) 2006-09-29

Similar Documents

Publication Publication Date Title
CN103179962B (zh) 丙二腈酰胺类似物在神经病理性疼痛中的用途
JPS63104931A (ja) 酸化に対して安定化された薬剤組成物
AU2003246774B2 (en) Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
JP2002506022A (ja) 新脈管形成の阻害
US20100056564A1 (en) Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
JP2005528376A5 (cg-RX-API-DMAC7.html)
HK1076034B (en) Novel association of an antithrombotic agent with aspirin and use thereof for the manufacture of a medicament for treating atherothrombotic diseases
JPH0680011B2 (ja) 血栓症の予防および治療用医薬
CA2720278A1 (en) Agent for preventing and/or treating vascular diseases
US20230218594A1 (en) Therapeutic compounds, compositions, and methods of use thereof
HK1093900B (en) Novel association consisting of an anti-atherothrombotic agent and of a platelet antiaggregating agent
Krupinski et al. Antithrombotic actions of indobufen in a model of laser induced arterial thrombosis
Ortega et al. Selective inhibition of ADP-induced calcium entry in rat platelets by PCA-4230 (trombodipine)
HK40029182A (en) Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, sodium bicarbonate, and l-theanine for the treatment of acute myocardial infarction

Legal Events

Date Code Title Description
FG Grant or registration